Chapter 38: Antibiotics Part 1

The chapter distinguishes between empiric therapy administered before culture results, definitive therapy tailored to identified pathogens, and prophylactic therapy used to prevent infection in susceptible populations. Critical concepts such as superinfection, which occurs when antibiotics eliminate normal flora allowing pathogenic overgrowth, and the emerging threat of multidrug-resistant organisms including methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococci, extended-spectrum beta-lactamase producers, and carbapenem-resistant Enterobacteriaceae establish the clinical context for antibiotic stewardship. The chapter covers multiple drug classes with distinct mechanisms and clinical applications. Sulfonamides and trimethoprim combinations serve as first-line agents for urinary tract infections and opportunistic infections in immunocompromised patients. Beta-lactam antibiotics comprise the largest group, including penicillins effective against gram-positive bacteria and some gram-negative species, cephalosporins organized by generation with progressively broader coverage, carbapenems representing the broadest-spectrum agents reserved for severe infections, and monobactams useful in patients with penicillin allergy. Macrolide antibiotics target respiratory pathogens, atypical bacteria, and organisms causing sexually transmitted infections. Tetracyclines demonstrate efficacy in rickettsial infections, spirochetal diseases, and acne but carry teratogenic and dental concerns in pediatric and pregnant populations. Throughout all classes, nursing implications encompass comprehensive allergy assessment to prevent hypersensitivity reactions and cross-reactivity, monitoring for adverse effects including gastrointestinal disturbances, photosensitivity, organ toxicity, and Clostridium difficile colitis, and patient education regarding completion of full treatment courses to maximize efficacy and minimize resistance development. Drug interactions with oral contraceptives, anticoagulants, and nonsteroidal anti-inflammatory agents require careful monitoring. Culture and sensitivity testing remains central to transitioning from empiric to targeted therapy, reducing unnecessary exposure and limiting selective pressure for resistance emergence.